|SEQ_NO||1||Date of announcement||2022/04/13||Time of announcement||13:39:39|
|Subject||Announcement of TTY Biopharm's unaudited income information in March 2022|
|Date of events||2022/04/13||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2022/04/13
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $367,243 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $81,126 thousands, and a consolidated income before tax of $109,405 thousands in March 2022; net income attributed to stockholders of the company was $88,323 thousands; EPS is $0.36.
Year-to-date consolidated net sales was $1,037,117 thousands (in NT dollars; unaudited), a consolidated operating profit was $246,564 thousands and consolidated income before tax was $287,248 thousands until March 2022; year-to-date net income attributed to stockholders of the company was $227,508 thousands; EPS is $0.91.
7.Any other matters that need to be specified:
The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.